{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T08:56:16Z","timestamp":1759481776558},"reference-count":53,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"vor","delay-in-days":31,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Congestive Heart Failure"],"published-print":{"date-parts":[[2007,5]]},"abstract":"<jats:p> <jats:italic>The conflicting results of diuretic treatments in heart failure (HF) and the importance of Na management in the context of the cardiorenal syndrome and neurohormonal activation in HF have suggested novel and counterintuitive strategies, focused primarily on the use of vasopressin antagonists and hypertonic saline solution with high doses of loop diuretics and their neurohormonal interference. The emerging novel therapies involving direct inhibition of vasopressin receptors appear to show promising results. The use of hypertonic saline solution mixed with a high dose of loop diuretics produces, probably by indirect mechanisms, a reduction or inhibition of the activated neurohormonal systems in HF patients. This treatment opens a new window on the role of sodium management in these patients and on the relation between sodium and the kidney's role and function in heart failure. The authors review the current evidence for these therapies and suggest hypothetical bases for their efficacy.<\/jats:italic> <\/jats:p>","DOI":"10.1111\/j.1527-5299.2007.06534.x","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T13:26:26Z","timestamp":1180704386000},"page":"170-176","source":"Crossref","is-referenced-by-count":9,"title":["Novel Strategies: Challenge Loop Diuretics and Sodium Management in Heart Failure\u2014Part II"],"prefix":"10.1111","volume":"13","author":[{"given":"Pietro Di","family":"Pasquale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo M.","family":"Sarullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatorew","family":"Paterna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,6]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.47.3.346"},{"key":"e_1_2_6_3_2","first-page":"125","volume-title":"Disturbances in Body Fluid Osmolality","author":"Robertson GL","year":"1977"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.1998.274.6.R1619"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1982.243.6.E522"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a015339"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119312"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.16.1963"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.73.5.485"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/hc4501.099313"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.05.015"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(89)90654-5"},{"key":"e_1_2_6_13_2","first-page":"219","article-title":"Tolerability and efficacy of high\u2010dose furosemide and small\u2010volume hypertonic saline solution in refractory congestive heart failure","volume":"16","author":"Paterna S","year":"1999","journal-title":"Adv Ther"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200019010-00002"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-9842(00)00094-5"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-198912000-00004"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2003.166"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2003.165"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.01.059"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.2001.281.2.R459"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1996.sp021261"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1067\/msy.2000.107606"},{"key":"e_1_2_6_23_2","first-page":"F615","article-title":"Renal and systemic effects of urodilatin in rats with high\u2010output heart failure","volume":"262","author":"Abassi ZA","year":"1992","journal-title":"Am J Physiol"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00738.2005"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1980.tb09721.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00119.2002"},{"key":"e_1_2_6_27_2","first-page":"581","article-title":"Diuretic resistance physiology and therapeutics","volume":"19","author":"Ellison DH","year":"1999","journal-title":"Semin Nephrol"},{"key":"e_1_2_6_28_2","first-page":"H629","article-title":"Dynamic fluid redistribution in hyperosmotic resuscitation of hypovolemic hemorrhage","volume":"255","author":"Mazzoni MC","year":"1988","journal-title":"Am J Physiol"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-102-3-314"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198530050-00003"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1159\/000176458"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365510500452955"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1988.189"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.6.1847"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4804(90)90174-Z"},{"key":"e_1_2_6_36_2","first-page":"1119","volume-title":"The Kidney: Physiology and Pathophysiology","author":"Hollenberg NK","year":"1985"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-114-10-886"},{"key":"e_1_2_6_38_2","first-page":"F1256","article-title":"Adaptation of the distal tubule and collecting duct to increased sodium delivery. I. Ultrastructure","volume":"255","author":"Kaissling B","year":"1988","journal-title":"Am J Physiol"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113847"},{"key":"e_1_2_6_40_2","first-page":"F137","article-title":"Adaptation of distal convoluted tubule of rats. II. Effects of chronic thiazide infusion","volume":"261","author":"Morsing P","year":"1991","journal-title":"Am J Physiol"},{"key":"e_1_2_6_41_2","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1210\/endo.134.6.8194476","article-title":"Brain natriuretic peptide in plasma, atria, and ventricles of vasopressin\u2010 and phenylephrine\u2010infused conscious rats","volume":"134","author":"Magga J","year":"1994","journal-title":"Endocrinology"},{"issue":"4","key":"e_1_2_6_42_2","first-page":"72A","article-title":"Sodium: old enemy or a new friend for advanced failure patients [abstract]","volume":"47","author":"Paterna S","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.2000.278.4.F585"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.10.042"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.03.028"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200525030-00002"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.1998.274.2.R263"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.73.2.257"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000165065.82609.3D"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108108"},{"key":"e_1_2_6_51_2","first-page":"129","article-title":"Changes in prostaglandin renal synthesis in cardiovascular disease","volume":"11","author":"Fontana F","year":"1989","journal-title":"Riv Eur Sci Med Farmacol"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-201X.2004.01351.x"},{"issue":"4","key":"e_1_2_6_53_2","first-page":"370A","article-title":"Aliskiren, an oral renin inhibitor, provides dose\u2010dependent efficacy, and placebo\u2010like tolerability in patients with hypertension [abstract]","volume":"47","author":"Oh BH","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000205761.22353.5f"}],"container-title":["Congestive Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1527-5299.2007.06534.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1527-5299.2007.06534.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T04:19:41Z","timestamp":1696997981000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1527-5299.2007.06534.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["10.1111\/j.1527-5299.2007.06534.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1527-5299.2007.06534.x","archive":["Portico"],"relation":{},"ISSN":["1527-5299","1751-7133"],"issn-type":[{"value":"1527-5299","type":"print"},{"value":"1751-7133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}